Exact Mass: 436.2825

Exact Mass Matches: 436.2825

Found 219 metabolites which its exact mass value is equals to given mass value 436.2825, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

simvastatin hydroxy acid

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid

C25H40O6 (436.2825)


simvastatin hydroxy acid is a metabolite of simvastatin. Simvastatin is a hypolipidemic drug used to control elevated cholesterol, or hypercholesterolemia. It is a member of the statin class of pharmaceuticals. Simvastatin is a synthetic derivate of a fermentation product of Aspergillus terreus. The drug is marketed generically and under the trade name Zocor. (Wikipedia) C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

   

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.2825)


DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.2825)


DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.2825)


DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoic acid

C25H40O6 (436.2825)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl 4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.2825)


DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl 4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.2825)


DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-3-(Acetyloxy)-2-hydroxypropyl 4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl 4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoic acid

C25H40O6 (436.2825)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoate

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoate

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C25H40O6 (436.2825)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C25H40O6 (436.2825)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Lancifodilactone F

(2S)-2-{(3R,3aR,5aR,7R,8S,10aS,10bS)-8-[(2S)-1,2-dihydroxypropan-2-yl]-3a,10b-dimethyl-5-oxotetradecahydro-1H,3H-spiro[cyclohepta[e]indene-7,2-furan]-3-yl}propanoic acid

C25H40O6 (436.2825)


Lancifodilactone F is a tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity. It has a role as a metabolite and an anti-HIV agent. It is an oxaspiro compound, a tetracyclic triterpenoid, a gamma-lactone, a diol and a monocarboxylic acid. A tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity.

   
   

Pancherin A

Pancherin A

C25H40O6 (436.2825)


   

Pancherin B

Pancherin B

C25H40O6 (436.2825)


   

Trichurusin B

Trichurusin B

C25H40O6 (436.2825)


   

(ent-2alpha,3beta,13Z)-3-Angeloyloxy-8(17),13-labdadiene-2,15,16,18-tetrol

(ent-2alpha,3beta,13Z)-3-Angeloyloxy-8(17),13-labdadiene-2,15,16,18-tetrol

C25H40O6 (436.2825)


   

13-hydroxy-7-oxolabda-8,14-diene 13(R)-O-alpha-L-arabinopyranoside

13-hydroxy-7-oxolabda-8,14-diene 13(R)-O-alpha-L-arabinopyranoside

C25H40O6 (436.2825)


   

6alpha,7beta-diacetoxy-13,14-dihydrokolavenic acid methyl ester

6alpha,7beta-diacetoxy-13,14-dihydrokolavenic acid methyl ester

C25H40O6 (436.2825)


   

methyl desacetylacamptoacetate

methyl desacetylacamptoacetate

C25H40O6 (436.2825)


   

9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin H

9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin H

C25H40O6 (436.2825)


   

hexadecane-1,16-diol 7-caffeoyl ester

hexadecane-1,16-diol 7-caffeoyl ester

C25H40O6 (436.2825)


   

18-methylmalonyl-epi-methyltrineracetal

18-methylmalonyl-epi-methyltrineracetal

C25H40O6 (436.2825)


   

2beta,3alpha-Dihydroxy-ent-labd-7-en-15-oic acid methyl ester diacetate

2beta,3alpha-Dihydroxy-ent-labd-7-en-15-oic acid methyl ester diacetate

C25H40O6 (436.2825)


   

3beta,8alpha,13,14-erythro-tetrahydroxy-labda-15,17-dien-16,19-olide

3beta,8alpha,13,14-erythro-tetrahydroxy-labda-15,17-dien-16,19-olide

C25H40O6 (436.2825)


   

methyl 7beta,15-diacetoxy-8-labden-17-oate

methyl 7beta,15-diacetoxy-8-labden-17-oate

C25H40O6 (436.2825)


   

(2alpha,3alpha,7alpha,12?鈥?13?鈥?-3-(2-Methylbutanoyl):2,3,7-Trihydroxy-8(17)-labden-15,12-olide|2alpha,7alpha-dihydroxy-3alpha(2-methylbutanoyloxy)8(17)-labden-12,15-olide

(2alpha,3alpha,7alpha,12?鈥?13?鈥?-3-(2-Methylbutanoyl):2,3,7-Trihydroxy-8(17)-labden-15,12-olide|2alpha,7alpha-dihydroxy-3alpha(2-methylbutanoyloxy)8(17)-labden-12,15-olide

C25H40O6 (436.2825)


   

6alpha-hydroxy-17-isovaleroxygrindelic acid

6alpha-hydroxy-17-isovaleroxygrindelic acid

C25H40O6 (436.2825)


   

12beta-O-acetyl-15alpha,28-dihydoxy-17beta-methoxy-3-oxo-20,21,22,23,24,25,26,27-octanordammanran

12beta-O-acetyl-15alpha,28-dihydoxy-17beta-methoxy-3-oxo-20,21,22,23,24,25,26,27-octanordammanran

C25H40O6 (436.2825)


   

6alpha,8alpha,15(S),23-tetrahydroxy-labd-13(14),17-dien-16(S),19-olide

6alpha,8alpha,15(S),23-tetrahydroxy-labd-13(14),17-dien-16(S),19-olide

C25H40O6 (436.2825)


   

palmadorin R

palmadorin R

C25H40O6 (436.2825)


   

palmadorin H

palmadorin H

C25H40O6 (436.2825)


   

SCHEMBL9179197

SCHEMBL9179197

C25H40O6 (436.2825)


   

(5S,8R,9S,10R,13S)-2-oxo-13-O-arabinopyranosyl-3,14-clerodadiene

(5S,8R,9S,10R,13S)-2-oxo-13-O-arabinopyranosyl-3,14-clerodadiene

C25H40O6 (436.2825)


   

3,3-dimethylundecan-2-yl 4-acetyl-2,3,6-trimethoxybenzoate|asiatoate A

3,3-dimethylundecan-2-yl 4-acetyl-2,3,6-trimethoxybenzoate|asiatoate A

C25H40O6 (436.2825)


   

Vulgaroside

Vulgaroside

C25H40O6 (436.2825)


   

secospatacetal A

secospatacetal A

C25H40O6 (436.2825)


   

Oriediterpenoside

Oriediterpenoside

C25H40O6 (436.2825)


   

isoagatholal-15-O-beta-D-xylopyranoside

isoagatholal-15-O-beta-D-xylopyranoside

C25H40O6 (436.2825)


   

(3aS,5R,5aS,6aS,7aS,8R,8aS,8bR)-dodecahydro-3a,8b-dihydroxy-5,7a-dimethyl-1-methylideneoxireno[6,7]naphtho[2,1-b]furan-8-yl decanoate|strobilol I

(3aS,5R,5aS,6aS,7aS,8R,8aS,8bR)-dodecahydro-3a,8b-dihydroxy-5,7a-dimethyl-1-methylideneoxireno[6,7]naphtho[2,1-b]furan-8-yl decanoate|strobilol I

C25H40O6 (436.2825)


   

salvisyriacolide

salvisyriacolide

C25H40O6 (436.2825)


   

6alpha-hydroxy-17-(alpha-methylbutyroxy)grindelic acid

6alpha-hydroxy-17-(alpha-methylbutyroxy)grindelic acid

C25H40O6 (436.2825)


   

methyl 3alpha,15-diacetoxy-labd-8(17)-en-19-oate

methyl 3alpha,15-diacetoxy-labd-8(17)-en-19-oate

C25H40O6 (436.2825)


   

Simvastatin acid

Simvastatin acid

C25H40O6 (436.2825)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

   

Diacetyl-10-gingerdiol

Diacetyl-10-gingerdiol

C25H40O6 (436.2825)


   

(-)-Salvisyriacolide

(-)-Salvisyriacolide

C25H40O6 (436.2825)


   

BIS(4-(VINYLOXYMETHYL)CYCLOHEXYLMETHYL)&

BIS(4-(VINYLOXYMETHYL)CYCLOHEXYLMETHYL)&

C25H40O6 (436.2825)


   

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C25H40O6 (436.2825)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C25H40O6 (436.2825)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C25H40O6 (436.2825)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C25H40O6 (436.2825)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C25H40O6 (436.2825)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C25H40O6 (436.2825)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C25H40O6 (436.2825)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C25H40O6 (436.2825)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C25H40O6 (436.2825)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C25H40O6 (436.2825)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C25H40O6 (436.2825)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

C25H40O6 (436.2825)


   

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C25H40O6 (436.2825)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

C25H40O6 (436.2825)


   

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C25H40O6 (436.2825)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

C25H40O6 (436.2825)


   

2-[(E)-5-[(1R,2R,4S,5S,6R,8aS)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl]-3-methyl-2H-uran-5-one

2-[(E)-5-[(1R,2R,4S,5S,6R,8aS)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl]-3-methyl-2H-uran-5-one

C25H40O6 (436.2825)


   

TG(22:3)

TG(4:0_6:0_12:3)

C25H40O6 (436.2825)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ST 19:1;O;Hex

ST 19:1;O;Hex

C25H40O6 (436.2825)


   
   

2-[(1as,2r,2as,3r,5's,6ar,7s,7as)-3,7-dihydroxy-1a,2a,5',6,6-pentamethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

2-[(1as,2r,2as,3r,5's,6ar,7s,7as)-3,7-dihydroxy-1a,2a,5',6,6-pentamethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H40O6 (436.2825)


   

ethyl (3r,5r)-7-[(1s,2s,8s,8ar)-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

ethyl (3r,5r)-7-[(1s,2s,8s,8ar)-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O6 (436.2825)


   

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

{5-[(acetyloxy)methyl]-1-[2-(5-methoxyoxolan-3-yl)ethyl]-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methyl acetate

{5-[(acetyloxy)methyl]-1-[2-(5-methoxyoxolan-3-yl)ethyl]-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methyl acetate

C25H40O6 (436.2825)


   

1,16-dihydroxyhexadecan-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

1,16-dihydroxyhexadecan-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C25H40O6 (436.2825)


   

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 2-methylbut-2-enoate

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)


   

ethyl 3,5-dihydroxy-7-{2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}heptanoate

ethyl 3,5-dihydroxy-7-{2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}heptanoate

C25H40O6 (436.2825)


   

1-[(1r,2r,4ar,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[(1r,2r,4ar,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

5-[4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

5-[4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C25H40O6 (436.2825)


   

methyl (3r)-5-[(1r,2s,3r,4r,4ar,8ar)-3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

methyl (3r)-5-[(1r,2s,3r,4r,4ar,8ar)-3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

C25H40O6 (436.2825)


   

1-{5-[7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl} 4-methyl butanedioate

1-{5-[7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl} 4-methyl butanedioate

C25H40O6 (436.2825)


   

methyl 5-[3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

methyl 5-[3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

C25H40O6 (436.2825)


   

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(2-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(2-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)


   

methyl (1r,2r,4ar,5s,8ar)-2-(acetyloxy)-5-[(3s)-5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl (1r,2r,4ar,5s,8ar)-2-(acetyloxy)-5-[(3s)-5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H40O6 (436.2825)


   

1-[(1s,2r,4as,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[(1s,2r,4as,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

(2r)-2-[(3s,3as,5as,7s,8r,10ar,10br)-8-[(2s)-1,2-dihydroxypropan-2-yl]-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

(2r)-2-[(3s,3as,5as,7s,8r,10ar,10br)-8-[(2s)-1,2-dihydroxypropan-2-yl]-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

C25H40O6 (436.2825)


   

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)


   

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

(5s)-5-[(2e)-5-[(1r,2r,4s,4ar,5r,6s,8as)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]-4-methyl-5h-furan-2-one

(5s)-5-[(2e)-5-[(1r,2r,4s,4ar,5r,6s,8as)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]-4-methyl-5h-furan-2-one

C25H40O6 (436.2825)


   

methyl 2-(acetyloxy)-5-[5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl 2-(acetyloxy)-5-[5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H40O6 (436.2825)


   

2-[8-(1,2-dihydroxypropan-2-yl)-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

2-[8-(1,2-dihydroxypropan-2-yl)-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

C25H40O6 (436.2825)


   

methyl (3r,5r)-7-[(1s,2s,6r,8s,8ar)-2,6-dimethyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

methyl (3r,5r)-7-[(1s,2s,6r,8s,8ar)-2,6-dimethyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O6 (436.2825)


   

1-{5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

1-{5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O6 (436.2825)


   

(2s,3s,4r,5r)-2-{[(3e)-4-[(2r,3r)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(3e)-4-[(2r,3r)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

C25H40O6 (436.2825)


   

(7r)-1,16-dihydroxyhexadecan-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(7r)-1,16-dihydroxyhexadecan-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C25H40O6 (436.2825)


   

(2s,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6r)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

(2s,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6r)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)


   

3,7-dihydroxy-1,1,4a-trimethyl-5-[(3-methyl-5-oxooxolan-2-yl)methyl]-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbutanoate

3,7-dihydroxy-1,1,4a-trimethyl-5-[(3-methyl-5-oxooxolan-2-yl)methyl]-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbutanoate

C25H40O6 (436.2825)


   

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O6 (436.2825)


   

(4as,8as)-3,4a,8,8-tetramethyl-4-[(3r)-3-methyl-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-4-en-1-yl]-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

(4as,8as)-3,4a,8,8-tetramethyl-4-[(3r)-3-methyl-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-4-en-1-yl]-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

C25H40O6 (436.2825)


   

(2s,3r,4as,5r,7r,8ar)-3,7-dihydroxy-1,1,4a-trimethyl-5-{[(2s,3r)-3-methyl-5-oxooxolan-2-yl]methyl}-6-methylidene-hexahydro-2h-naphthalen-2-yl (2r)-2-methylbutanoate

(2s,3r,4as,5r,7r,8ar)-3,7-dihydroxy-1,1,4a-trimethyl-5-{[(2s,3r)-3-methyl-5-oxooxolan-2-yl]methyl}-6-methylidene-hexahydro-2h-naphthalen-2-yl (2r)-2-methylbutanoate

C25H40O6 (436.2825)


   

2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

C25H40O6 (436.2825)


   

3,4a,8,8-tetramethyl-4-{3-methyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-4-en-1-yl}-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

3,4a,8,8-tetramethyl-4-{3-methyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-4-en-1-yl}-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

C25H40O6 (436.2825)


   

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-({[(2r)-2-methylbutanoyl]oxy}methyl)-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-({[(2r)-2-methylbutanoyl]oxy}methyl)-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)


   

(1s,2r,6s,8r,9s,11s,13s,14r)-2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

(1s,2r,6s,8r,9s,11s,13s,14r)-2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

C25H40O6 (436.2825)


   

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O6 (436.2825)


   

3-hydroxy-5-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbut-2-enoate

3-hydroxy-5-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)


   

(1s,4ar,5s,8ar)-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

(1s,4ar,5s,8ar)-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

C25H40O6 (436.2825)


   

[(1s,2s,3r,5r,10r,11r,14s,16r,17r)-3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl]methyl acetate

[(1s,2s,3r,5r,10r,11r,14s,16r,17r)-3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl]methyl acetate

C25H40O6 (436.2825)


   

{3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl}methyl acetate

{3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl}methyl acetate

C25H40O6 (436.2825)


   

4-methyl-5-[(2z)-3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl]-5h-furan-2-one

4-methyl-5-[(2z)-3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl]-5h-furan-2-one

C25H40O6 (436.2825)


   

(5e)-5-[(2s,3s)-5-[(1r,2r,4ar,6s,8as)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

(5e)-5-[(2s,3s)-5-[(1r,2r,4ar,6s,8as)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

C25H40O6 (436.2825)


   

(2s,3r,4r,5s)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

(2s,3r,4r,5s)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)


   

1-(2e)-5-[(1s,4ar,5s,7r,8ar)-7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl 4-methyl butanedioate

1-(2e)-5-[(1s,4ar,5s,7r,8ar)-7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl 4-methyl butanedioate

C25H40O6 (436.2825)


   

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)


   

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

4-methyl-5-{3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl}-5h-furan-2-one

4-methyl-5-{3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl}-5h-furan-2-one

C25H40O6 (436.2825)


   

(1s,2s,3s,4as,5r,8as)-3-hydroxy-5-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

(1s,2s,3s,4as,5r,8as)-3-hydroxy-5-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)


   

(2s,3r)-2-[(2r,4s,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

(2s,3r)-2-[(2r,4s,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)


   

(2e)-5-[(4r,4ar,5s,6r,8as)-4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

(2e)-5-[(4r,4ar,5s,6r,8as)-4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C25H40O6 (436.2825)


   

2-(4,6-dimethyloct-6-en-2-yl)-6-oxooxan-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

2-(4,6-dimethyloct-6-en-2-yl)-6-oxooxan-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)


   

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)


   

1-[(1s,2r,4as,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[(1s,2r,4as,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl 3-methylbut-2-enoate

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl 3-methylbut-2-enoate

C25H40O6 (436.2825)


   

(2s,3s,4r,5r)-2-{[(3e)-4-[(2s,3s)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(3e)-4-[(2s,3s)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

C25H40O6 (436.2825)


   

1-[(1r,2r,4ar,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[(1r,2r,4ar,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

[(1s,2r,4as,8ar)-5-[(acetyloxy)methyl]-1-{2-[(3r,5r)-5-methoxyoxolan-3-yl]ethyl}-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl acetate

[(1s,2r,4as,8ar)-5-[(acetyloxy)methyl]-1-{2-[(3r,5r)-5-methoxyoxolan-3-yl]ethyl}-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl acetate

C25H40O6 (436.2825)


   

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)


   

(1s,3s,3ar,3br,5ar,6r,9ar,9br,11r,11as)-3-hydroxy-6-(hydroxymethyl)-1-methoxy-3a,3b,6,9a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-11-yl acetate

(1s,3s,3ar,3br,5ar,6r,9ar,9br,11r,11as)-3-hydroxy-6-(hydroxymethyl)-1-methoxy-3a,3b,6,9a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-11-yl acetate

C25H40O6 (436.2825)


   

4,8-dihydroxy-12-(3-hydroxy-3-methylpent-4-en-1-yl)-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl 2-methylbut-2-enoate

4,8-dihydroxy-12-(3-hydroxy-3-methylpent-4-en-1-yl)-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)


   

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 3-methylbut-2-enoate

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 3-methylbut-2-enoate

C25H40O6 (436.2825)


   

(1r,3r,4s,6r,8r,9r,12s)-4,8-dihydroxy-12-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl (2z)-2-methylbut-2-enoate

(1r,3r,4s,6r,8r,9r,12s)-4,8-dihydroxy-12-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)


   

2-[(6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

2-[(6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)


   

(5e)-5-[5-(2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

(5e)-5-[5-(2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

C25H40O6 (436.2825)


   

1,4a-dimethyl-5-{3-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-3-en-1-yl}-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

1,4a-dimethyl-5-{3-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-3-en-1-yl}-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

C25H40O6 (436.2825)


   

(2r,3s,4s,5s)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl 3-methylbut-2-enoate

(2r,3s,4s,5s)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl 3-methylbut-2-enoate

C25H40O6 (436.2825)